,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-06-17 07:00:00,The following are the top rated Healthcare stocks according to Validea's Patient Investor model based on the published strategy of Warren Buffett .,0.043228548020124435,0.004656202159821987,0.9521152973175049,neutral,0.038572344928979874
1,2018-06-17 07:00:00,"This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.",0.20986133813858032,0.006538537796586752,0.7836001515388489,neutral,0.20332279801368713
2,2018-06-17 07:00:00,BIOGEN INC ( BIIB ) is a large-cap growth stock in the Biotechnology & Drugs industry.,0.6385758519172668,0.010137596167623997,0.35128650069236755,positive,0.6284382343292236
3,2018-06-17 07:00:00,The rating according to our strategy based on Warren Buffett is 93% based on the firm's underlying fundamentals and the stock's valuation.,0.032949190586805344,0.005188412964344025,0.9618624448776245,neutral,0.02776077762246132
4,2018-06-17 07:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
5,2018-06-17 07:00:00,Company Description: Biogen Inc. is a biopharmaceutical company.,0.015894627198576927,0.0073434701189398766,0.9767618775367737,neutral,0.00855115707963705
6,2018-06-17 07:00:00,"The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases.",0.06928692013025284,0.00443440955132246,0.9262787103652954,neutral,0.0648525133728981
7,2018-06-17 07:00:00,"The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis ( MS ), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA).",0.05885586515069008,0.004554904066026211,0.9365891814231873,neutral,0.05430096015334129
8,2018-06-17 07:00:00,"It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies.",0.4847475290298462,0.009223067201673985,0.5060294270515442,neutral,0.4755244553089142
9,2018-06-17 07:00:00,"The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.",0.05369625240564346,0.005773114040493965,0.9405306577682495,neutral,0.04792314022779465
10,2018-06-17 07:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
11,2018-06-17 07:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
12,2018-06-17 07:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

INTUITIVE SURGICAL, INC. ( ISRG ) is a large-cap growth stock in the Medical Equipment & Supplies industry.",0.637584924697876,0.010514910332858562,0.3519001305103302,positive,0.6270700097084045
13,2018-06-17 07:00:00,The rating according to our strategy based on Warren Buffett is 77% based on the firm's underlying fundamentals and the stock's valuation.,0.030332785099744797,0.005116732325404882,0.9645504951477051,neutral,0.025216052308678627
14,2018-06-17 07:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
15,2018-06-17 07:00:00,"Company Description: Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories.",0.02185518853366375,0.006197228562086821,0.9719475507736206,neutral,0.015657959505915642
16,2018-06-17 07:00:00,"The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system.",0.020238682627677917,0.007399392314255238,0.9723619222640991,neutral,0.01283929031342268
17,2018-06-17 07:00:00,"The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.",0.02189486473798752,0.010379241779446602,0.9677258729934692,neutral,0.011515622958540916
18,2018-06-17 07:00:00,"The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition ( HD ) vision.",0.14674335718154907,0.005833636038005352,0.8474230170249939,neutral,0.14090971648693085
19,2018-06-17 07:00:00,"Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System.",0.08619140088558197,0.005270529538393021,0.9085380434989929,neutral,0.08092087507247925
20,2018-06-17 07:00:00,The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.,0.01875384896993637,0.00609822990372777,0.9751479625701904,neutral,0.012655619531869888
21,2018-06-17 07:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
22,2018-06-17 07:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
23,2018-06-17 07:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

CHEMED CORPORATION ( CHE ) is a mid-cap growth stock in the Healthcare Facilities industry.",0.6597837209701538,0.011822779662907124,0.32839342951774597,positive,0.6479609608650208
24,2018-06-17 07:00:00,The rating according to our strategy based on Warren Buffett is 72% based on the firm's underlying fundamentals and the stock's valuation.,0.030370399355888367,0.005157763138413429,0.9644718766212463,neutral,0.025212636217474937
25,2018-06-17 07:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
26,2018-06-17 07:00:00,"Company Description: Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities.",0.011717860586941242,0.015495296567678452,0.9727867841720581,neutral,-0.0037774359807372093
27,2018-06-17 07:00:00,The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter).,0.01573348417878151,0.008234535343945026,0.9760319590568542,neutral,0.007498948834836483
28,2018-06-17 07:00:00,"The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.",0.03774503991007805,0.00505264475941658,0.9572023153305054,neutral,0.03269239515066147
29,2018-06-17 07:00:00,"VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices.",0.06378064304590225,0.005517643876373768,0.9307016730308533,neutral,0.05826300010085106
30,2018-06-17 07:00:00,VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs.,0.06600417196750641,0.0052005574107170105,0.9287952780723572,neutral,0.0608036145567894
31,2018-06-17 07:00:00,A portion of its VITAS business is operated in the state of Florida.,0.009832967072725296,0.008557763881981373,0.9816092848777771,neutral,0.0012752031907439232
32,2018-06-17 07:00:00,"The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.",0.017693769186735153,0.006039993837475777,0.9762662649154663,neutral,0.011653775349259377
33,2018-06-17 07:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
34,2018-06-17 07:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
35,2018-06-17 07:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

HENRY SCHEIN, INC. (HSIC) is a large-cap growth stock in the Medical Equipment & Supplies industry.",0.4482971429824829,0.008918996900320053,0.5427838563919067,neutral,0.43937814235687256
36,2018-06-17 07:00:00,The rating according to our strategy based on Warren Buffett is 72% based on the firm's underlying fundamentals and the stock's valuation.,0.030370399355888367,0.005157763138413429,0.9644718766212463,neutral,0.025212636217474937
37,2018-06-17 07:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
38,2018-06-17 07:00:00,"Company Description: Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners.",0.03628134727478027,0.0052106487564742565,0.9585080146789551,neutral,0.03107069805264473
39,2018-06-17 07:00:00,"The Company operates through two segments: healthcare distribution, and technology and value-added services.",0.016387267038226128,0.00638753455132246,0.9772252440452576,neutral,0.009999732486903667
40,2018-06-17 07:00:00,"The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.",0.015017230994999409,0.007259625010192394,0.9777231216430664,neutral,0.0077576059848070145
41,2018-06-17 07:00:00,"The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners.",0.02448747307062149,0.005064907018095255,0.9704475998878479,neutral,0.019422566518187523
42,2018-06-17 07:00:00,Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics.,0.020227594301104546,0.005537560675293207,0.9742348194122314,neutral,0.014690034091472626
43,2018-06-17 07:00:00,"The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.",0.025317931547760963,0.004989595152437687,0.9696924686431885,neutral,0.020328335464000702
44,2018-06-17 07:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
45,2018-06-17 07:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
46,2018-06-17 07:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

ATRION CORPORATION (ATRI) is a small-cap growth stock in the Medical Equipment & Supplies industry.",0.18076102435588837,0.008135713636875153,0.8111032247543335,neutral,0.17262530326843262
47,2018-06-17 07:00:00,The rating according to our strategy based on Warren Buffett is 70% based on the firm's underlying fundamentals and the stock's valuation.,0.03360789269208908,0.005126818083226681,0.9612652659416199,neutral,0.028481073677539825
48,2018-06-17 07:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
49,2018-06-17 07:00:00,"Company Description: Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications.",0.025596510618925095,0.005554968025535345,0.968848466873169,neutral,0.020041542127728462
50,2018-06-17 07:00:00,The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products.,0.035694245249032974,0.004387657158076763,0.9599180817604065,neutral,0.031306587159633636
51,2018-06-17 07:00:00,Its fluid delivery products include valves that promote infection control and needle safety.,0.0630858764052391,0.004490142222493887,0.9324239492416382,neutral,0.05859573557972908
52,2018-06-17 07:00:00,"It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology.",0.1092182919383049,0.004592310171574354,0.8861894011497498,neutral,0.10462598502635956
53,2018-06-17 07:00:00,"Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables.",0.05825990065932274,0.004943076521158218,0.936797022819519,neutral,0.05331682413816452
54,2018-06-17 07:00:00,The Company manufactures specialized medical devices that disinfect contact lenses.,0.030124420300126076,0.005777555517852306,0.9640979766845703,neutral,0.024346865713596344
55,2018-06-17 07:00:00,Its other medical and non-medical product lines consist of instrumentation and associated disposables.,0.013242238201200962,0.0068062664940953255,0.9799514412879944,neutral,0.006435971707105637
56,2018-06-17 07:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
57,2018-06-17 07:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
58,2018-06-17 07:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

Since its inception, Validea's strategy based on Warren Buffett has returned 219.39% vs. 161.84% for the S&P 500.",0.42765140533447266,0.5334790945053101,0.0388694703578949,negative,-0.1058276891708374
59,2018-06-17 07:00:00,"For more details on this strategy, click here

About Warren Buffett : Warren Buffett is considered by many to be the greatest investor of all time.",0.1991606056690216,0.011050635948777199,0.7897887825965881,neutral,0.18810996413230896
60,2018-06-17 07:00:00,"As the chairman of Berkshire Hathaway, Buffett has consistently outperformed the S&P 500 for decades, and in the process has become one of the world's richest men.",0.7431123852729797,0.038232944905757904,0.21865463256835938,positive,0.7048794627189636
61,2018-06-17 07:00:00,(Forbes puts his net worth at $37 billion.),0.021339498460292816,0.011338518932461739,0.967322051525116,neutral,0.010000979527831078
62,2018-06-17 07:00:00,"Despite his fortune, Buffett is known for living a modest lifestyle, by billionaire standards.",0.03567022085189819,0.03917572647333145,0.9251540899276733,neutral,-0.003505505621433258
63,2018-06-17 07:00:00,"His primary residence remains the gray stucco Nebraska home he purchased for $31,500 nearly 50 years ago, according to Forbes, and his folksy Midwestern manner and penchant for simple pleasures -- a cherry Coke, a good burger, and a good book are all near the top of the list -- have been well-documented.",0.10358904302120209,0.011022992432117462,0.8853879570960999,neutral,0.09256605058908463
64,2018-06-17 07:00:00,About Validea : Validea is an investment research service that follows the published strategies of investment legends.,0.01593991555273533,0.006665502674877644,0.9773945808410645,neutral,0.009274412877857685
65,2018-06-17 07:00:00,"Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig.",0.08751807361841202,0.010206559672951698,0.9022754430770874,neutral,0.07731151580810547
66,2018-06-17 07:00:00,"For more information about Validea, click here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.009221813641488552,0.018771808594465256,0.9720064401626587,neutral,-0.009549994952976704
